UBC is launching a new COVID-19 rapid testing clinic for any students living in residence and other select groups living and working on the Vancouver campus....
Impact Stories | Page 3
Twenty-minute saliva-based COVID-19 test may be coming soon to a pharmacy near you.
Researchers at the University of Waterloo are developing a new COVID-19 test that can be administered at home using saliva, aiming to deliver a positive or negative result in less than 20 minutes....
McMaster researchers developing homegrown vaccines to fight COVID-19 and prevent future outbreaks, using specialized campus lab and production facility
A team of virologists, infectious disease experts and immunologists at McMaster is developing two new second-generation COVID-19 vaccine candidates, designing and producing them in a specialized facility on campus....
A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke....
Many older adults in Canada don’t regularly walk outdoors, despite limits to the activity impacting mobility, social isolation and other quality of life factors. In 2021, a year into the COVID-19 pandemic, the risks may be even higher than normal....
Molnupiravir under consideration for emergency use in India to slow explosive spread of COVID-19 infections....
The University of Toronto is bringing together researchers, pharmaceutical innovators and government partners to address gaps in Canada’s biomanufacturing ecosystem and discuss solutions for public health challenges such as COVID-19....
Before entering the lab each morning, Mariya Goncheva, PhD, puts on clean scrubs, two pairs of booties, two pairs of gloves, a gown and a full hood that covers her entire head and shoulders. She is connected by a hose to a positive pressure powered air respirator which pumps clean air into the hood....
UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly infectious nature and rapid spread of variant B.1.1.7....